Molecular diagnostic solutions for respiratory infection testing

Prompt and early diagnosis of respiratory pathogens that cause severe illness is critical to help inform patient management, treatment decisions, and preventing the spread of disease.  Confidence in testing results allows clinicians and patients to make informed decisions—including seeking medical care and/or helping to prevent contact with other people. While many testing options are available for respiratory testing, molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.


TaqPath COVID-19, Flu A, Flu B, RSV Select Panel

The Applied Biosystems TaqPath COVID‑19, Flu A, Flu B, RSV Select Panel is a multiplex, real-time reverse transcription polymerase chain reaction (RT-PCR) in vitro diagnostic test for the qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus, influenza B virus, and respiratory syncytial virus (RSV).


TaqPath COVID-19 Diagnostic PCR Kit

The TaqPath COVID-19 Diagnostic PCR Kit is a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acids from SARS-CoV-2 in nasopharyngeal and anterior nasal specimens from individuals with signs and symptoms of respiratory tract infection.


For In Vitro Diagnostic Use.